Activesite Pharmaceuticals is a research lab that uses proprietary technology to search for potential drug candidates for an assortment of diseases. They have received a grant from the National Institute of Health for novel orally-active plasma kallikrein inhibitors for diabetic retinopathy. They also have a patent that was issued in 2009 for "Inhibitors of Plasma Kallikrein."